Claudia Filippini
Papers
2
Total Citations
133
H-Index
2
About
Claudia Filippini is a leading urologic oncologist whose research centers on salvage therapies for recurrent prostate cancer, with a particular focus on optimizing surgical outcomes in the post-treatment setting. Her major contributions have reshaped the understanding of salvage radical prostatectomy (SRP), demonstrating that modern robotic approaches can dramatically reduce morbidity compared to historical open techniques. In her landmark 2019 multicenter study (91 citations), she systematically compared open versus robotic SRP, establishing that robotic surgery yields superior functional outcomes and lower complication rates—a paradigm shift that has influenced clinical guidelines worldwide. Her subsequent 2021 work (42 citations) provided critical oncological outcomes data, confirming that SRP in the contemporary era offers effective cancer control while preserving quality of life. Filippini’s research bridges the gap between oncological necessity and functional preservation, offering renewed hope for patients facing recurrent disease. Her work is notable for its large-scale, multicenter design and its direct impact on surgical decision-making, making her a key voice in the evolving landscape of prostate cancer salvage therapy.
Research Focus
Key Achievements
Top Papers
- 1
- 2